Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-07-29

Clinical Trial Update: Effect of Fermented Soybean (FSB) Supplementation on Gas-troesophageal Reflux Disease (GERD) [NA]

View source ↗

Summary

A completed clinical trial assessing whether fermented soybean supplementation (FSB) affects gastroesophageal reflux disease (GERD).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fermented Soybean Supplement (FSB) (Fermented soybean supplement)

Snippet

Sponsor: NATTOME SDN BHD | Conditions: Gastro Esophageal Reflux | NA | Status: COMPLETED